iDtheinvestordatabase
Home / Directory / Eos Advisory
Likely active: portfolio news Mar 2026 Verified 4 Nov 2026

Eos Advisory

St Andrews-based investor, founded 2014, that runs an angel syndicate, an annual seed-stage Innovation Fund and a Venture Partners co-investment route into science and technology companies. It backs quality-of-life and environmental sustainability businesses such as diagnostics, therapeutics, food and water security and clean energy.

Type
Angel network
Location
St Andrews, United Kingdom
Stages
Seed, Series A, Growth
Backs
Biotech and pharma
Sectors
Healthtech and life sciences, Biotech, Robotics, AI, Climate and cleantech, Deep tech
SEIS / EIS
SEIS and EIS
Portfolio mix
Biotech and pharma 47%; Medtech and digital health 13%; Hardware 13%; Deep tech 13%; B2B software 7%; Climate and energy 7% (n=15)

Contacts on file

For Eos Advisory, the paid file holds: 7 named decision-makers with roles; firm contact email (domain checked); check size; LinkedIn page.

Get UK Complete, $149 Free sample

One-time payment. No subscription. No account.

Notable investments

DxcoverBiolibertyNaturbeadsLaverock TherapeuticsChemify

Sources

Last checked 4 Nov 2026. Is something wrong? Tell us.

Appears in 40 lists